Abstract
The different modalities of tissue damage produced by immunologic mechanisms are, generally speaking, chronically progressive, sometimes disfiguring, and frequently lethal. Control of their clinical manifestations has been attempted with corticosteroids, but therapy with these hormones has limitations arising from their nonspecificity, the irregularity with which they act in certain immunologic diseases — for example, in chronic glomerulonephritides — and in the production of undesirable side effects when used for long periods of time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bach JF (1975) The mode of action of immunosuppressive agents. North Holland Amsterdam
Cortesini R (ed) (1979) Modulation of immunologic responsiveness. Transplant Proc 11:839
Fauci AS, Dale DC, Balow JE (1976) Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 84:304
Gerber NL, Steinberg AD (1976) Clinical use of immunosuppressive drugs (2 parts). Drugs 11:14, 90
Kaplan SR, Calabresi P (1973) Immunosuppressive agents (2 parts). N Engl J Med 289:952, 1234
Lance EM, Medawar PB, Taub RN (1973) Antilym-phocytic serum. Adv Immunol 17:2
Parker CW, Vaura JD (1974) Immunosuppression. Prog Hematol 6:1
Schein PS, Winokur SH (1975) Immunosuppressive and cytotoxic chemotherapy: Long term complications. Ann Intern Med 82:84
Winkelstein A (1977) Effects of immunosuppressive drugs on T and B lymphocytes. Blood 50:81
Rights and permissions
Copyright information
© 1981 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
da Silva, W.D. (1981). Immunosuppression. In: Fundamentals of Immunology. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-0116-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0116-5_14
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-90529-7
Online ISBN: 978-1-4684-0116-5
eBook Packages: Springer Book Archive